Legacy Cancer Institute earns the Outstanding Achievement Award from the American College of Surgeons’ Commission on Cancer
Legacy the first in the region to receive award three accreditation survey cycles in a row.
Legacy Cancer Institute announced today it has been awarded the 2016 Outstanding Achievement Award by the Commission on Cancer (CoC) of the American College of Surgeons (ACS) for the third accreditation survey cycle in a row – the first provider in Oregon to do so.
Legacy Cancer Institute is one of a select group of 20 U.S. accredited cancer programs to receive this national honor for surveys performed January 1 – June 30, 2016.
In order to achieve this distinction, Legacy Cancer Institute met or exceeded each of the CoC’s 34 program standards with no deficiencies. In other words, the outside experts evaluating Legacy found that nothing about Legacy’s cancer care needs correction and that it is a national leader in all cancer activity areas.
“The Outstanding Achievement Award assures our patients and their families that they are getting the highest level of care possible when treated at Legacy,” said Nathalie Johnson, M.D
., FACS, medical director of Legacy Cancer Institute and Legacy Breast Health Centers. “Being accredited by the American College of Surgeons’ Commission on Cancer means our patients are being screened and treated by a multidisciplinary team that works around the clock to ensure our patients have the best odds of survival and can return to quality life.”
The purpose of the award is to encourage cancer programs to raise the bar on quality cancer care, with the ultimate goal of increasing awareness about high quality, patient-centered care. In addition, the award is intended to:
• recognize Legacy for achieving excellence meeting the CoC Standards;
• motivate other cancer programs to work toward improving their level of quality cancer care as Legacy has done;
• facilitate dialogue between Legacy and health care professionals at other cancer facilities for the purpose of sharing best practices and;
• encourage Legacy to serve as quality-care resources to other cancer programs.
Legacy Cancer Institute was evaluated on 34 program standards categorized within five cancer program activity areas: cancer committee leadership, cancer data management, clinical services, patient outcomes, and data quality. The cancer program was further evaluated on seven commendation standards. To be eligible, all award recipients must have received commendation ratings in all seven commendation standards, in addition to receiving a compliance rating for each of the 27 other standards.
About Legacy Cancer Institute
Legacy Cancer Institute is a recognized authority on the prevention and treatment of cancer that treats over 2600 patients per year. Its multi-disciplinary team includes some of the region's most recognized surgeons for all major cancer sites including breast, colorectal and gynecologic; pathologists, diagnostic radiologists, medical and radiation oncologists as well a team of genetics specialists, nurse navigators, therapists and patient support staff to guide and support patients at every stage of treatment. In addition, Legacy Cancer Institute conducts ongoing clinical trials, houses the Comprehensive Cancer Healing Center and is the first and only health system to offer 3-D mammography services to every patient, every time, at multiple locations.
About the American College of Surgeons Commission on Cancer
Established in 1922 by the ACS, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of comprehensive quality care. The CoC’s accreditation program encourages hospitals, treatment centers, and other facilities to improve their quality of patient care through various cancer-related services. For more information on the CoC, visit: https://www.facs.org/quality-programs/cancer/coc
For media-related inquiries, contact Megan Deisler.